DRIO Key Statistics, Chart & Performance
The current stock price of DRIO is 10.04 USD. In the past month the price decreased by -16.12%. In the past year, price decreased by -27.77%.
DRIO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 29.02 | 36.93B | ||
| DOCS | DOXIMITY INC-CLASS A | 26.64 | 8.23B | ||
| WAY | WAYSTAR HOLDING CORP | 24.61 | 6.31B | ||
| HTFL | HEARTFLOW INC | N/A | 2.54B | ||
| CERT | CERTARA INC | 17.78 | 1.42B | ||
| SDGR | SCHRODINGER INC | N/A | 1.35B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.26B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 636.75 | 1.08B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.03B | ||
| PHR | PHREESIA INC | N/A | 1.02B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 7.86 | 933.43M | ||
| HSTM | HEALTHSTREAM INC | 34.72 | 700.51M |
Related stock screener links
About DRIO
Company Profile
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company is headquartered in New York City, New York and currently employs 196 full-time employees. The company went IPO on 2013-03-08. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Company Info
DARIOHEALTH CORP
322 W 57Th St. #33B
New York City NEW YORK 10019 US
CEO: Erez Raphael
Employees: 199
Phone: 16466654667
DARIOHEALTH CORP / DRIO FAQ
What does DRIO do?
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company is headquartered in New York City, New York and currently employs 196 full-time employees. The company went IPO on 2013-03-08. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
What is the current price of DRIO stock?
The current stock price of DRIO is 10.04 USD.
Does DRIO stock pay dividends?
DRIO does not pay a dividend.
What is the ChartMill technical and fundamental rating of DRIO stock?
DRIO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is DRIO stock listed?
DRIO stock is listed on the Nasdaq exchange.
How is the valuation of DARIOHEALTH CORP (DRIO) based on its PE ratio?
DARIOHEALTH CORP (DRIO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.24).
Can you provide the upcoming earnings date for DARIOHEALTH CORP?
DARIOHEALTH CORP (DRIO) will report earnings on 2026-03-09, after the market close.
DRIO Technical Analysis
DRIO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DRIO. DRIO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
DRIO Financial Highlights
Over the last trailing twelve months DRIO reported a non-GAAP Earnings per Share(EPS) of -5.24. The EPS increased by 74.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.52% | ||
| ROE | -49.53% | ||
| Debt/Equity | 0.41 |
DRIO Forecast & Estimates
10 analysts have analysed DRIO and the average price target is 18.61 USD. This implies a price increase of 85.41% is expected in the next year compared to the current price of 10.04.
For the next year, analysts expect an EPS growth of -118.81% and a revenue growth -10.78% for DRIO